We then examined the specific associations of altered excitatory and inhibitory neuronal subpopulation parameters and Aβ- and tau-tracer uptake patterns and how these contribute to produce the characteristic spectral changes in AD patients. This evidence concerns the gene MAPT and Alzheimer disease.